Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 16 July 2009, Vol. 114, No. 3, pp. 499-500.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Rosen, S. D.
Right arrow Articles by Arata-Kawai, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, S. D.
Right arrow Articles by Arata-Kawai, H.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

InsideBlood

VASCULAR BIOLOGY

Comment on Hernandez Mir et al, page 733

"Home sweet home" for lymphocytes

Steven D. Rosen, and Hanayo Arata-Kawai

UNIVERSITY OF CALIFORNIA, SAN FRANCISCO

In this issue of Blood, Hernandez Mir and colleagues provide the most detailed analysis to date of the glycans on an HEV-expressed ligand (CD34) isolated from a human lymphoid organ, (tonsils), adding to our understanding of how L-selectin mediates lymphocyte homing.

As part of the process of immune surveillance, lymphocytes in the blood migrate ("home") to secondary lymphoid organs by interacting with and crossing high endothelial venules (HEVs).1 For naive lymphocytes and some memory subpopulations, the multistep recruitment process begins with L-selectin–mediated tethering and rolling of lymphocytes along HEVs. The HEV ligands, which are cognate to L-selectin, are sialomucins, such as CD34, podocalyxin-like protein, endomucin and others. Many of these ligands were either identified or verified with MECA-79, a mAb that blocks lymphocyte binding to lymph node HEVs in mice but also crossreacts with HEVs in many species, including those in human lymphoid organs.2 The collection of sulfated sialomucin ligands carrying the MECA-79 epitope is generally referred to as "PNAd." Of apparent general importance across species is the 6-sulfo sLex structure (sialyl Lewis X with 6-O-sulfation on GlcNAc), which serves as a recognition determinant on the carbohydrate chains of these ligands.1,3 In mice, we have fairly detailed structural information about the O-glycans on HEV-expressed ligands.4,5 The structure, 6-sulfo sLex, is found as a capping structure on core-2 and "extended" core-1 branches of these O-glycans (see Hernandez Mir et al for detailed structures6). MECA-79 recognizes the latter branch with an absolute dependency on 6-O-sulfation.4

To remedy the relative lack of information about human ligands, Hernandez Mir et al undertook a structural analysis of CD34 isolated from human tonsils. They first isolated total CD34 from a detergent lysate of tonsils on a column of immobilized CD34 mAb. Next, to obtain the relevant glycoforms of CD34, they performed affinity chromatography on a high-density L-selectin chimera column. Using mass spectrometry (sometimes in combination with exoglycosidase digestions), the authors were able to make assignments or educated guesses for the structures of the O-glycans associated with the L-selectin binding (ligand glycoforms) versus nonbinding species. Strikingly, the ligand O-glycans are much more complex than those associated with nonbinding CD34, with the fucosylated and sulfated species present only in the former. Consistent with the function-blocking activity of MECA-79, the ligand fraction contains all of the MECA-79 reactivity, verifying the usefulness of this antibody for identifying ligand scaffold proteins. There is a daunting assortment of 5 identifiable O-glycans that terminate with 6-sulfo sLex and probably several others but with structures too complex to decipher. Thus, it appears likely that there is not a single type of chain recognized by L-selectin but several. In total, about 20% of the O-glycans within the ligand glycoforms of CD34 are capped by 6-sulfo sLex. Hernandez Mir et al favor a model in which clustering of the 6-sulfo sLex determinant on the CD34 scaffold enhances the avidity of L-selectin binding.

The relative paucity of the MECA-79 reactive structure among the 5 O-glycans provides a plausible explanation of why this antibody only partially inhibits lymphocyte attachment to tonsillar HEVs.2 Also, the new findings may help to rationalize those endothelial ligands for L-selectin which don't react with MECA-79.5 A comprehensive analysis of ligand function in mouse has uncovered the participation of 6-sulfo sLex on N-glycans of CD34.7 Hernandez Mir et al also identify N-glycans on tonsillar CD34 with "potential" 6-sulfo sLex caps. These N-glycans are dispensable for interaction with the L-selectin affinity column, but further functional analysis is needed before firm conclusions can be drawn.

MECA-79 reactive vessels (frequently with an HEV-like morphology) are induced in a wide variety of chronic inflammatory settings, including rheumatoid arthritis, asthma, ulcerative colitis, heart and kidney allografts, H pylori–induced gastritis, and so on.2,5,8 By analogy with the function of HEVs in lymphoid organs, it is suspected that the L-selectin/PNAd system is involved in the recruitment of lymphocytes into these inflamed tissues. As the recruited lymphocytes might contribute to disease, therapeutic possibilities exist for antibodies that target L-selectin ligands.5 At this juncture, IgG antibodies with reactivity to L-selectin recognition determinants on both O- and N-glycans would seem most desirable.

The study by Hernandez Mir et al illustrates the value (and challenges) of solving the carbohydrate structures of a selectin ligand. With continuing advances in highly sensitive methods for sequencing carbohydrate chains, one can anticipate further illuminating investigations of the ligands for endogenous carbohydrate-binding proteins such as galectins, Siglecs, and C-type lectins.


Figure 1
View larger version (190K):
[in this window]
[in a new window]

 
MECA-79 staining of vessels in ulcerative colitis. A section of inflamed colonic mucosa from an ulcerative colitis patient was immunostained with MECA-79 by standard procedures. Signal (brown) is present on vascular endothelial cells in several HEV-like vessels. This result is in agreement with the report of Kobayashi et al.9 The immunohistochemistry was performed by Mark Singer. The paraffin block was provided (UCSF Committee of Human Research approval no. H1060-28 724). This research was supported by NIH grants by Dr Annemieke Van Zante, Department of Pathology, UCSF. R01-GM57411 and R01-GM23547 to S.D.R.

 

Footnotes

Conflict-of-interest disclosure: The authors declare no competing financial interests. {blacksquare}

REFERENCES

  1. Rosen SD. Ligands for L-selectin: homing, inflammation, and beyond. Ann Rev Immunol. 2004;22:129–156.[CrossRef][Medline] [Order article via Infotrieve]

  2. Michie SA, Streeter PR, Bolt PA, et al. The human peripheral lymph node vascular addressin. Am J Pathol. 1993;143:1688–1698.[Abstract]

  3. Kannagi R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr Opin Struct Biol. 2002;12:599–608.[CrossRef][Medline] [Order article via Infotrieve]

  4. Kawashima H, Petryniak B, Hiraoka N, et al. N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat Immunol. 2005;6:1096–1104.[CrossRef][Medline] [Order article via Infotrieve]

  5. Uchimura K, Rosen SD. Sulfated L-selectin ligands as a therapeutic target in chronic inflammation. Trends Immunol. 2006;27:559–565.[CrossRef][Medline] [Order article via Infotrieve]

  6. Hernandez Mir G, Helin J, Skarp K-P, et al. Glycoforms of human endothelial CD34 that bind L-selectin carry sulfated sialyl Lewis x capped O- and N-glycans. Blood. 2009;114:733–741.[Abstract/Free Full Text]

  7. Mitoma J, Bao X, Petryanik B, et al. Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment. Nat Immunol. 2007;8:409–418.[CrossRef][Medline] [Order article via Infotrieve]

  8. Renkonen J, Tynninen O, Hayry P, Paavonen T, et al. Glycosylation might provide endothelial zip codes for organ-specific leukocyte traffic into inflammatory sites. Am J Pathol. 2002;161:543–550.[Abstract/Free Full Text]

  9. Kobayashi M, Hoshino H, Masumoto J, et al. GlcNAc6ST-1–mediated decoration of MAdCAM-1 protein with L-selectin ligand carbohydrates directs disease activity of ulcerative colitis. Inflamm Bowel Dis. 2009;15:697–706.[CrossRef][Medline] [Order article via Infotrieve]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Article in Blood Online:

Glycoforms of human endothelial CD34 that bind L-selectin carry sulfated sialyl Lewis x capped O- and N-glycans
Gerard Hernandez Mir, Jari Helin, Kari-Pekka Skarp, Richard D. Cummings, Antti Mäkitie, Risto Renkonen, and Anne Leppänen
Blood 2009 114: 733-741. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Rosen, S. D.
Right arrow Articles by Arata-Kawai, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, S. D.
Right arrow Articles by Arata-Kawai, H.
Related Collections
Right arrowRelated Article in Blood Online
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020